Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Transpl Infect Dis. 2023 Dec;25(6):e14113. doi: 10.1111/tid.14113. Epub 2023 Aug 18.
Recent advances in antimicrobial resistance detection have spurred the development of multiple assays that can accurately detect the presence of bacterial resistance from positive blood cultures, resulting in faster institution of effective antimicrobial therapy. Despite these advances, there are limited data regarding the use of these assays in solid organ transplant (SOT) recipients and there is little guidance on how to select, implement, and interpret them in clinical practice. We describe a practical approach to the implementation and interpretation of these assays in SOT recipients using the best available data and expert opinion. These findings were part of a consensus conference sponsored by the American Society of Transplantation held on December 7, 2021 and represent the collaboration between experts in transplant infectious diseases, pharmacy, antimicrobial and diagnostic stewardship, and clinical microbiology. Areas of unmet need and recommendations for future investigation are also presented.
近年来,抗菌药物耐药性检测技术取得了新进展,多种检测方法可从阳性血培养中准确检测出细菌耐药性,从而更快地实施有效的抗菌药物治疗。尽管取得了这些进展,但有关这些检测方法在实体器官移植(SOT)受者中的应用的数据有限,并且在临床实践中如何选择、实施和解释这些检测方法方面的指导意见也很少。我们使用现有最佳数据和专家意见,描述了一种在 SOT 受者中实施和解释这些检测方法的实用方法。这些发现是美国移植学会于 2021 年 12 月 7 日赞助的共识会议的一部分,代表了移植感染病学、药学、抗菌药物和诊断管理以及临床微生物学领域专家的合作。本共识还提出了目前尚未满足的需求领域和未来研究建议。